.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Machine-learning approaches have been investigated as early-warning tools for sepsis, using electronic-health-record data such as vital signs, laboratory values, medications and prior diagnoses to identify patterns associated with impending deterioration. One influential body of work demonstrated that a continuously updated prediction model could identify patients at elevated sepsis risk hours before traditional clinical recognition in retrospective and prospective validation settings. The promise is clear: earlier warning could support faster assessment, source control, antimicrobial therapy and escalation of monitoring. However, predictive accuracy alone does not prove improved patient outcomes. Models can suffer from dataset shift, missing data, alert fatigue and hidden biases related to how care is delivered. For general physicians, this means AI should be treated as decision support rather than an autonomous diagnostic authority. The clinician still needs to assess the patient, verify the plausibility of the prediction and consider alternative explanations. APICON's “AI vs clinical judgment” framing is therefore clinically important: the best systems may be those that augment human pattern recognition and prioritize attention without replacing accountability, examination and contextual reasoning.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Machine-learning approaches have been investigated as early-warning tools for sepsis, using electronic-health-record data such as vital signs, laboratory values, medications and prior diagnoses to identify patterns associated with impending deterioration. One influential body of work demonstrated that a continuously updated prediction model could identify patients at elevated sepsis risk hours before traditional clinical recognition in retrospective and prospective validation settings. The promise is clear: earlier warning could support faster assessment, source control, antimicrobial therapy and escalation of monitoring. However, predictive accuracy alone does not prove improved patient outcomes. Models can suffer from dataset shift, missing data, alert fatigue and hidden biases related to how care is delivered. For general physicians, this means AI should be treated as decision support rather than an autonomous diagnostic authority. The clinician still needs to assess the patient, verify the plausibility of the prediction and consider alternative explanations. APICON's “AI vs clinical judgment” framing is therefore clinically important: the best systems may be those that augment human pattern recognition and prioritize attention without replacing accountability, examination and contextual reasoning.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
